Shares of Elmet Group shifted sharply higher Monday, climbing 7.1% to $18.59 as buyers piled into the defense-materials maker for a second straight session. The move extends a rebound from last week's bruising slide — the stock fell from $22.09 on June 2 to $17.17 by June 5 — and raises the question of whether the fundamentals can sustain a stock that remains volatile less than two months after its debut.

  • Defense Spending Is Filling the Order Book. Elmet's open order backlog jumped to roughly $113.3 million, up from $96.3 million at the end of Q4 2025 and $74.7 million a year earlier — a 52% year-over-year surge. The growth was driven primarily by the company's critical-materials division, which gained $9.1 million in revenue from aerospace, defense, and government customers. For shareholders, a record backlog means greater revenue visibility over the next several quarters, but it also pressures Elmet to scale production without eroding margins.

  • Profits Are Real, but the GAAP Picture Is Messier. Q1 revenue rose 20.7% to $56 million , and adjusted EBITDA — essentially operating cash earnings before one-time items — more than doubled to $9.2 million. Yet the company posted a small net loss of about $0.3 million, driven by a $3.8 million one-time tax charge tied to its corporate reorganization. Investors banking on adjusted numbers need to watch whether those "one-time" costs keep recurring as the company matures as a public entity.

  • IPO Cash Gives Elmet Room to Grow — and Obligations to Prove It. Elmet sold roughly 9.9 million shares at $14.00 apiece, raising $125.5 million in net proceeds.

After retiring $17.8 million in debt and paying $8.3 million in stock-related costs, it kept about $99.4 million in cash. At today's price, the stock trades about 33% above its IPO level — a meaningful premium that pressures management to deploy that cash into growth that justifies the valuation.

  • Volatility Is the Price of a Thin Trading History. Shares opened at $18.00 on their first day of Nasdaq trading on April 23 , ran above $22, then gave it all back in days. With barely seven weeks of price history and a limited analyst following, sharp swings in either direction are likely until the company builds a longer public track record and institutional holders settle in.